Skip over main navigation
  • Log in
  • Basket: (0 items)
  • Perth Blood Institute
  • Thrombosis Australia
  • Thrombosis Australia Professionals
The Perth Blood Institute Limited
  • Search
  • Facebook
  • Linkedin
  • Email
  • Search
  • Facebook
  • Linkedin
  • Email
Login Register Subscribe Donate
Menu
  • Who we are
    • Vision, mission and values
    • What we do
    • Our facilities
    • Our team
      • Board
      • Investigators
      • Thrombosis Australia Advisory Panel
    • Work with us
  • Our clinical trials
    • Clinical trials
    • Collaborations
    • Participate in a clinical trial
    • Useful links
  • Our research
    • Current research projects
    • Research highlights
    • Research collaborations
      • PBI
      • APTIN
    • Participate in a research project
    • Published research
  • About blood disorders
    • Overview
    • Blood disorders
      • Anaemia
      • Antiphospholipid syndrome (APS)
      • Haemophilia
      • Polycythemia vera
      • Thrombocythaemia
      • Thrombophilia
      • TTP
      • von Willebrand Disease
    • Blood cancers
      • Myelofibrosis (MF)
      • Chronic lymphocytic leukaemia
      • Lymphoma
    • For patients and families
  • Personal stories
    • Living with a blood disorder
  • Get involved
    • Donate
    • Fundraise
    • Partner with us
    • Leave a gift in your will
    • Other ways to help
  • News and events
    • Latest news & info
    • Previous news
    • 10 Year Anniversary
    • Significant days
      • 2023
      • 2022
    • Media
    • Upcoming events
    • Publications
  • COVID-19
  • Admin
    • Log in
    • Perth Blood Institute
    • Thrombosis Australia
    • Thrombosis Australia Professionals
  • Basket: (0 items)

Thrombosis Australia Advisory Panel

We have established an advisory panel to provide oversight and direction to Thrombosis Australia, to ensure that the information we provide is current and accurate. The panel consists of eminent healthcare professionals that collectively bring a wealth of experience and knowledge to the Thrombosis Australia Initiative. The breadth of their collective experience covers a range of clinical and academic interests relating to blood disorders, including distinguished editorial roles, clinical trial design and management, teaching, and extensive authorship.

The advisory panel sets the benchmark for the quality, accuracy, and currency of information by critically evaluating and reviewing content, and offers dynamic perspectives and advice to maintain oversight of the purpose and usefulness of the Thrombosis Australia Initiative in the fight against venous thromboembolism.

The panel is chaired by Professor Ross Baker, founding director the Perth Blood Institute.                       


Dr Jennifer Curnow MBBS, FRACP, FRCPA, PhD

Dr Jennifer Curnow received her FRACP and FRCPA in Haematology in 2004/2005 and is the Director of Clinical Haematology for Western Sydney LHD at Westmead Hospital. Dr Curnow is a former president of the Thrombosis and Haemostasis Society of Australia (formerly the Australasian Society of Thrombosis and Haemostasis) and is chair of the THANZ Education subcommittee. Dr Curnow is also co-author of multiple national and state guidance documents for thrombosis and haemostasis. Dr Curnow chairs the NSW Clinical Excellence Commission Anticoagulant medicines working party.  


Prof Graeme J. Hankey MBBS MD FRCP FRCPEdin FRACP FAHA FESO FWSO FAAHMS

Graeme Hankey is Professor of Neurology at The University of Western Australia, and a Consultant Neurologist at Sir Charles Gairdner Hospital. He is an Associate Editor of Circulation, Editorial Consultant for The Lancet Neurology, a consulting Editor of the International Journal of Stroke, and Section co-Editor for the Epidemiology, Outcomes, & Population Science section of Stroke.  He is a Web of Science Highly Cited Researcher for 2017-2019, co-authoring 10 books and >900 research articles, with > 100,000 citations (h-index 121).


Professor Shirley Jansen PhD FRACS FRCS MBChB

Shirley Jansen is Professor of Vascular Surgery at Curtin University, and both Head of Department and Consultant Vascular and Endovascular Surgeon at Sir Charles Gairdner Hospital. She is Director of the Heart & Vascular Research Institute, Programme Lead Cardiovascular at Harry Perkins Institute for Medical Research and Adjunct Clinical Professor at the University of WA. Shirley has broad research interests in vascular and endovascular surgery with over 60 published research papers and 4 book chapters. She has extensive experience conducting clinical trials as primary investigator including first in man.


Dr Jamie Price FRACP FRCPA

Dr Jamie Price graduated from UWA in 1973. Dr Price was a resident at Princess Margaret and Royal Perth Hospital and specialises in haematology. Dr Price was appointed Clinical Haematologist at PMH and worked in haematology and oncology for over 30 years. His special interests are in paediatric haematology, bleeding disorders, and thrombotic disorders. One of his major objectives was in the prophylaxis of haemophilia and the preservation of joint function in haemophiliac patients.                     


Dr Peter Purnell MBBS FRACP FCSANZ

Dr Purnell is a cardiovascular imaging specialist based in Perth, WA. He was previously Head of Department of Cardiology at Joondalup Health Campus and currently works in research and private practice. His primary clinical interests are in heart failure, coronary disease, valvular heart disease, stroke prevention in atrial fibrillation, and cardio-oncology. He set up GenesisCare Cardio-Oncology service in WA in 2018 for medical oncology, expanded in 2019 to cover radiation oncology. Dr Purnell is the founding Director of Joondalup Cardiovascular Trials Inc., an independent, not-for-profit research organisation. He is also Head of Research GenesisCare Cardiology Western Australia.


Professor Huyen Tran MBBS (Hons) Master Clin Epi FRACP FRCPA

Professor Huyen Tran is a Professor at Australian Centre for Blood Diseases, Monash University, and Director of the Ronald Sawers Haemophilia Treatment Centre and Clinical Thrombosis Service, The Alfred Hospital. Both of these organisations undertake research based on their specialisation.  Prof Tran has over 75 publications in peer-reviewed journals, has been involved in clinical trials for 20 years and contributes to several advisory boards. He is Chair of the Australian Haemophilia Centre Director's Organisation, and Chair of the Clinical Trials Group of the Thrombosis and Haemostasis Society of Australia and New Zealand.


Published: 15th December, 2020

Updated: 12th August, 2021

Author: Jake Harfield

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Atrial fibrillation - Research 2021-2022

  • CAT - Research 2021-2022

  • Iron Deficiency Day 2023

    Iron Deficiency Day 2023

    World Iron Deficiency Day on the 26th of November provides an opportunity to emphasise the importance and significance of this universal health condition.

  • World Stroke Day 2023

    World Stroke Day 2023

    Stroke is the second leading cause of death worldwide with millions of people affected every year. October 29 is World Stroke Day and provides an opportunity to remind everyone how important healthy blood vessels are and reduce the risk of stroke.

Most read

  • What is thrombosis?

    What is thrombosis?

    Click here to learn more about thrombosis.

  • What are DVT & PE?

    What are DVT & PE?

    Click here to learn more about DVT and PE.

  • Work and Thrombosis

    Work and Thrombosis

    Click here to learn more about how work can increase your risk of thrombosis, and how to prevent it.

  • Travel and Thrombosis

    Travel and Thrombosis

    Click here to learn about how travel can increase your risk of developing dangerous blood clots.

  • Contraception and Thrombosis

    Contraception and Thrombosis

    Click here to learn more about how certain contraceptives can increase your risk of dangerous blood clots.

  • Antiphospholipid Antibody Syndrome

    Antiphospholipid Antibody Syndrome

    Click here for information about antiphospholipid antibody syndrome and how it can lead to thrombosis.

  • Inherited Thrombophilias

    Inherited Thrombophilias

    Click here for information about genetic conditions that can increase the chances of thrombosis.

  • Investigators

    Investigators

  • PCOS and thrombosis

    PCOS and thrombosis

    Polycystic Ovary Syndrome (PCOS) is a hormonal disorder and one of the most common endocrine system and reproductive disorders among women. Here we provide some information regarding its association with thrombosis.

  • Participate in a clinical trial

    Participate in a clinical trial

    PBI's Clinical Trials Unit actively runs numerous clinical trials and performs state-of-the-art research into bleeding and clotting disorders and blood cancers.

Tag cloud

Acute Myeloid Leukaemia ADAMTS13 blood clots cancer contraceptive Follicular Lymphoma haemophilia A Microangiopathic Thrombocytopenia multiple myeloma oral contraceptive pregnancy Relapsed Multiple Myeloma small vessels thrombosis Thrombotic Thrombocytopaenic Pupura TMA
Donate today

Donate today

Please help to make blood disorders a thing of the past. Every amount is vital to our research, no matter how large or small. Read more

Donate Fundraise

Published: 18th February, 2020

Updated: 8th May, 2023

Author:

SUPERNOVA clinical trial

SUPERNOVA clinical trial

Perth Blood Institute (PBI) start new Australian-wide clinical trial – SUPERNOVA Read more

Published: 3rd July, 2023

Updated: 2nd August, 2023

Author: Gina Rodgers

Comments: 1

PBI celebrates 10 Year Anniversary!

PBI celebrates 10 Year Anniversary!

"It is with your support that we have continued to grow over the past 10 years – to continue to advance medical discoveries and improve care for patients. " Professor Ross Baker Read more

Published: 4th July, 2023

Updated: 21st September, 2023

Author: Bec Morgan

Graham Wild

Graham Wild

Graham Wild, a passionate 15-year-old boy with a deep love for nature and animals, had dreams of running an animal sanctuary. After returning from a trip to see his dad, Graham started to have trouble breathing and his health rapidly deteriorated. Despite urgent medical attention, his heart stopped, and he couldn't be revived. Graham's mother Kathryn would like to share his story. Read more

Published: 13th July, 2023

Updated: 14th September, 2023

Author: Jacqui Le

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Helpful links

  • Sitemap
  • Accessibility
  • Terms & conditions
  • Privacy policy
  • Contact us

Contact

18 Prowse Street
West Perth
WA 6005
P : +61 8 9200 5300
F : +61 8 9200 5324
E : [email protected]

  • Facebook
  • Instagram
  • Linkedin
  • Email

PBI is registered as an Income Tax Exempt Charity
CFN: CC21886
ACN: 164 941 815
ABN: 24 164 941 815

© Perth Blood Institute 2020